G
LIVE

Serial Number

87111373

Owner

Granules India Limited

Attorney

Daniel Christopherson

Filing Date

Jul 21, 2016

Add to watchlist:

No watchlists yet
View on USPTO

G Trademark

Serial Number: 87111373 • Registration: 5150840

G is a trademark filed by Granules India Limited on July 21, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Granules India Limited (7 trademarks)

2nd Floor, 3rd Block, My Home Hub
Hyderabad, TG 500081 , IN

Entity Type: 99

Trademark Details

Filing Date

July 21, 2016

Registration Date

February 28, 2017

Published for Opposition

December 13, 2016

Goods & Services

Acetaminophen; Analgesics; Anti-inflammatories; Anticoagulants; Antifungal preparations; Antihistamines; Antipyretic analgesics; Cough expectorants; Cough treatment preparations; Expectorants; Ibuprofen for use as an oral analgesic; Muscle relaxants; Pain relief medication; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-diabetic pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for antiretroviral use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-fibrotic use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-fungal use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-hypertensive use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-ulcerative use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-infective use; Cough expectorants; Cough treatment preparations; Paracetamol; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Therapeutic pharmaceutical for the treatment of multiple screlosis

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 28, 2026 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 6, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 6, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 6, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 30, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 28, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2016 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 4, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 1, 2016 XAEC
ASSIGNED TO LIE
Nov 1, 2016 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 1, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 1, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 1, 2016 CNEA
ASSIGNED TO EXAMINER
Nov 1, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 27, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2016 NWOS
NEW APPLICATION ENTERED
Jul 25, 2016 NWAP